| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2007, p. 220-228, Vol. 27, No. 1
0270-7306/07/$08.00+0 doi:10.1128/MCB.00899-06

Xitong Yuan,1,
,
Kristin Beebe,1
Zhexin Xiang,2,
and
Len Neckers1*
Urologic Oncology Branch, National Cancer Institute,1 Center for Molecular Modeling, Center for Information Technology, National Institutes of Health, Bethesda, Maryland 208922
Received 19 May 2006/ Returned for modification 21 June 2006/ Accepted 24 September 2006
The receptor tyrosine kinase ErbB2 plays a crucial role in tumorigenesis. We showed previously that the molecular chaperone Hsp90 protects ErbB2 from proteasome-mediated degradation by binding to a short loop structure in the N-lobe of the kinase domain. Here we show that loss of Hsp90 binding correlates with enhanced ErbB2 kinase activity and its transactivating potential, concomitant with constitutively increased phosphorylation of Tyr877, located in the activation loop of the kinase domain. We show further that Tyr877 phosphorylation is mediated by Src and that it is necessary for the enhanced kinase activity of ErbB2. Finally, computer modeling of the kinase domain suggests a phosphorylation-dependent reorientation of the activation loop, denoting the importance of Tyr877 phosphorylation for ErbB2 activity. These findings suggest that Hsp90 binding to ErbB2 participates in regulation of kinase activity as well as kinase stability.
Published ahead of print on 9 October 2006.
W.X., X.Y., and Z.X. contributed equally to this work.
Present address: Beijing Institute of Disease Control and Prevention, Beijing 100039, China.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|